Educational information, not medical advice — ask your doctor or midwife.
Goshajinkigan (GJG) is a ten-herb Kampo formula that evolved from the classical Chinese formula Bawei Dihuang Wan (Eight-Ingredient Rehmannia Pill) by adding Achyranthes and Plantain seed to better target lower-body symptoms like leg pain, numbness, and bladder problems. It has been used in Japan for over 400 years and is today an officially approved prescription Kampo medicine under Japan's national health insurance. Modified versions of the formula may adjust ingredient ratios or substitute specific herbs to improve tolerability or target particular conditions.
The formula is thought to work by supporting what Kampo calls 'kidney yang' — the body's warming, activating energy — which governs nerve function, fluid balance, and lower-limb strength as we age. Modern research suggests the herbs collectively help regulate nerve signaling, reduce inflammation in nerve tissue, support healthy blood flow to the extremities, and calm overactive bladder muscle contractions. Rehmannia and Cornus provide nourishing antioxidant compounds, while Cinnamon and processed Aconite are believed to improve circulation and warm peripheral tissues.
In Japan, Goshajinkigan is most commonly dispensed as standardized extract granules (the Tsumura TJ-107 product is the most studied), which dissolve in hot water or are taken directly. Tablets and capsules are available for convenience. Traditional decoction — simmering the whole herbs — is still used by classical practitioners and is considered the most potent form. Outside Japan, encapsulated extract powders from Chinese or Korean producers are most common.
The original formula traces to the Song Dynasty Chinese text 'Ji Sheng Fang' (济生方, c. 1253 CE), authored by Yan Yonghe. Japanese Kampo physicians adopted and refined it over centuries, and the modified ten-herb version became standard in Japan. Today it is one of the most prescribed Kampo formulas in Japanese hospitals, particularly in urology and neurology departments, and has accumulated a meaningful body of modern clinical trial data, especially for diabetic neuropathy and overactive bladder.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.